Medicare Enrolled
Dr. Muhammad Imam, MD
Hematology · Winter Park, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Imam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Imam?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Imam
Dr. Muhammad Imam is a hematology specialist in Winter Park, FL, with 16 years of NPI registration. Based on federal Medicare data, Dr. Imam performed 51,070 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Imam received a total of $21,383 from 63 pharmaceutical and/or device companies across 348 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Imam is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years of NPI registration
▲ 51,070 Medicare services
$21,383 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 127609 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗51,070
Medicare services
Bottom 37% in FL for hematology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 18,800 | $43 | $137 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
13,260 | $0 | $4 |
| Anti-nausea injection (aprepitant) | 4,680 | $1 | $5 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
2,810 | $6 | $23 |
| Denosumab injection (Prolia/Xgeva) | 2,640 | $18 | $51 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,592 | $0 | $3 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,455 | $8 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,412 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 740 | $1 | $28 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
529 | $12 | $61 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
512 | $94 | $339 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
511 | $66 | $239 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
465 | $97 | $378 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
273 | $10 | $69 |
| Anti-nausea injection (ondansetron/Zofran) | 240 | $0 | $9 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
180 | $1 | $3 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
133 | $21 | $79 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
133 | $48 | $178 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
105 | $4 | $15 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
105 | $47 | $189 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
82 | $7 | $69 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
75 | $21 | $84 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
70 | $24 | $89 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
60 | $1 | $6 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
56 | $126 | $453 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
37 | $4 | $10 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
33 | $42 | $170 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
31 | $2 | $8 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
26 | $94 | $285 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
14 | $63 | $197 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
11 | $125 | $467 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
27.5% high complexity
64.4% medium
8.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$21,383
Total received (2018-2024)
Avg $3,055/year across 7 years
Top 21% in FL for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
348
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,876
2023
$3,588
2022
$1,487
2021
$1,027
2020
$211
2019
$9,228
2018
$3,967
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$418
AstraZeneca Pharmaceuticals LP
$205
Celgene Corporation
$161
DePuy Synthes Sales Inc.
$126
Takeda Pharmaceuticals U.S.A., Inc.
$109
Gilead Sciences, Inc.
$93
Janssen Biotech, Inc.
$79
Bayer Healthcare Pharmaceuticals Inc.
$72
Astellas Pharma US Inc
$58
ABBVIE INC.
$46
BeiGene USA, Inc.
$44
PFIZER INC.
$41
Genentech USA, Inc.
$37
Coherus Biosciences Inc.
$34
Exelixis Inc.
$32
ADC Therapeutics America, Inc.
$28
GENZYME CORPORATION
$26
PharmaEssentia USA Corporation
$26
Kite Pharma, Inc.
$26
Genmab U.S., Inc.
$24
Dendreon Pharmaceuticals LLC
$22
TerSera Therapeutics LLC
$22
Lilly USA, LLC
$21
E.R. Squibb & Sons, L.L.C.
$20
JAZZ PHARMACEUTICALS INC.
$20
SOBI, INC
$20
Karyopharm Therapeutics Inc.
$19
Eisai Inc.
$18
Pharmacosmos Therapeutics Inc.
$15
Merck Sharp & Dohme LLC
$14
Top 3 companies account for 41.8% of 2024 payments
All-time payments by company (2018-2024) ›
Bayer HealthCare Pharmaceuticals Inc.
$12,164
Novartis Pharmaceuticals Corporation
$2,112
AstraZeneca Pharmaceuticals LP
$1,959
Celgene Corporation
$557
Janssen Biotech, Inc.
$456
E.R. Squibb & Sons, L.L.C.
$444
PFIZER INC.
$243
Genentech USA, Inc.
$238
Kite Pharma, Inc.
$202
Merck Sharp & Dohme LLC
$191
Gilead Sciences, Inc.
$183
Seagen Inc.
$178
NOVARTIS PHARMACEUTICALS CORPORATION
$167
BeiGene USA, Inc.
$155
Takeda Pharmaceuticals U.S.A., Inc.
$148
Lilly USA, LLC
$140
DePuy Synthes Sales Inc.
$126
Astellas Pharma US Inc
$118
Myovant Sciences Inc.
$96
Bayer Healthcare Pharmaceuticals Inc.
$91
Amgen Inc.
$88
Karyopharm Therapeutics Inc.
$73
JAZZ PHARMACEUTICALS INC.
$73
GENZYME CORPORATION
$63
GlaxoSmithKline, LLC.
$58
Pharmacyclics LLC, An AbbVie Company
$56
ADC Therapeutics America, Inc.
$56
EMD Serono, Inc.
$52
Ipsen Biopharmaceuticals, Inc
$50
Alexion Pharmaceuticals, Inc.
$47
Daiichi Sankyo Inc.
$46
ABBVIE INC.
$46
Incyte Corporation
$45
Foundation Medicine, Inc.
$42
ARRAY BIOPHARMA INC
$36
CSL Behring
$35
G1 Therapeutics, Inc.
$34
Coherus Biosciences Inc.
$34
Exelixis Inc.
$32
Rigel Pharmaceuticals, Inc.
$30
Puma Biotechnology, Inc.
$29
MEDIVATION FIELD SOLUTIONS LLC
$26
PharmaEssentia USA Corporation
$26
Stemline Therapeutics Inc.
$24
Genmab U.S., Inc.
$24
Dendreon Pharmaceuticals LLC
$22
TerSera Therapeutics LLC
$22
SOBI, INC
$20
RECORDATI_RARE_DISEASES_INC.
$19
Servier Pharmaceuticals LLC
$18
Mirati Therapeutics, Inc.
$18
Eisai Inc.
$18
CTI BioPharma Corp.
$18
Apellis Pharmaceuticals, Inc.
$17
Pharmacosmos Therapeutics Inc.
$15
Pharmacyclics LLC, an AbbVie Company
$15
Deciphera Pharmaceuticals Inc.
$15
Veracyte, Inc.
$14
Verastem, Inc.
$13
NanoString Technologies, Inc.
$12
Merck Sharp & Dohme Corporation
$12
Adaptive Biotechnologies Corporation
$12
SECURA BIO, INC.
$11
Top 3 companies account for 75.9% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · Afstyla · Alecensa · Aliqopa · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · COPIKTRA · COSELA · CYRAMZA · Copiktra · DARZALEX · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Empaveli · Enhertu · Epkinly · Erleada · FOUNDATIONONE · FRUZAQLA · GAZYVA · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · Idelvion · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LUMAKRAS · LYNPARZA · Lenvima · Lunsumio · MYLOTARG · NINLARO · Nerlynx · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · Orserdu · PADCEV · PANHEMATIN · PLUVICTO · PROSIGNA ASSAY · PROVENGE · Padcev · Perjeta · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · SARCLISA · SCEMBLIX · SOLIRIS · SUTENT · Stivarga · TALVEY · TASIGNA · TRUMATCH · Tavalisse · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VONJO · Venclexta · Vonjo · XALKORI · XPOVIO · XTANDI · Xofigo · Xospata · Yescarta · ZEPZELCA · ZIIHERA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematologists in nearby ZIP areas
20
County median income
$77,011
Nearest hospital to ZIP centroid (approximate)
ADVENTHEALTH ORLANDO
3.0 mi
3.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Imam is a mixed practice specialist, with moderate Medicare volume, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Imam experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Imam performed 18,800 pembrolizumab injection (keytruda) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Imam receive payments from pharmaceutical companies?
Yes. Dr. Imam received a total of $21,383 from 63 companies across 348 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Imam's costs compare to other hematologists in Winter Park?
Dr. Imam's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Imam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Winter Park
Browse hematologists in Winter Park ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology